Intrahepatic Cholangiocarcinoma

Oncology·MeSH: Disease Progression

Prevalence

2.5 / 100K

Incidence

1.3 / 100K/yr

7 drugs in development·7 companies·11 clinical trials

Drug Pipeline by Phase

Phase 2(1)
DrugCompany
vg2025IO Biotech, Inc. (IOBT)

Compare drugs

CGT4859 vs derazantinibCGT4859 vs FOLFIRI or FOLFOX or RegorafenibCGT4859 vs hmpl-453

Frequently asked questions

How many drugs are in development for Intrahepatic Cholangiocarcinoma?

BioSniper tracks 7 drugs in development for Intrahepatic Cholangiocarcinoma across 7 companies.

How many clinical trials target Intrahepatic Cholangiocarcinoma?

There are 11 clinical trials targeting Intrahepatic Cholangiocarcinoma tracked by BioSniper.

What is the prevalence of Intrahepatic Cholangiocarcinoma?

The estimated prevalence of Intrahepatic Cholangiocarcinoma is approximately 2.5 per 100,000 population.

Deep-dive into Intrahepatic Cholangiocarcinoma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Intrahepatic Cholangiocarcinoma — Drugs in Development & Clinical Trials | BioSniper